Researchers and managers from the Institut de Recerca Sant Pau (IR Sant Pau) took part in the 3rd Conference of ISCIII Platforms for Support of R&D&I in Biomedicine and Health Sciences, held in Salamanca from October 27 to 29. The event, organized by the Instituto de Salud Carlos III (ISCIII), brought together more than 400 professionals from hospitals, health research institutes, universities, and public administrations, with the goal of promoting cooperation among the scientific infrastructures that support biomedical research in Spain.
This annual conference is the main meeting point for the three platforms promoted by the ISCIII: the ISCIII Platform for Biomodels and Biobanks, the ISCIII ITEMAS Platform (Innovation and Dynamization of the Industrial Capabilities of the National Health System), and the ISCIII SCReN Platform (Support for Independent Clinical Research). Each of these platforms plays a strategic role in advancing translational research and health innovation by promoting shared resources, common methodologies, and synergies among centers across the country.
The IR Sant Pau participated actively in all three platforms, contributing to discussions on current challenges and collaboration opportunities in the field of biomedical research. Key topics included the ethical and quality management of biobanks, technological innovation in hospitals, knowledge transfer to the industrial sector, and the role of independent clinical trial units in generating scientific evidence.
During the conference, Dr. Rosa Maria Antonijoan from IR Sant Pau and Hospital Sant Pau moderated the session “Interactive Discussion of Practical Cases” within the SCReN Platform track, together with Dr. Inma Fuentes from the Vall d’Hebron Institute of Research (VHIR). The session provided an opportunity to share real-world experiences in the management and coordination of clinical studies, highlighting the importance of collaborative networks and the methodological and regulatory support offered by the platform for independent research.
IR Sant Pau’s participation in this event reflects its commitment to scientific excellence, collaborative networking, and translational research aimed at improving clinical practice. Its involvement in the ISCIII platforms helps strengthen the research capacity of the healthcare system, foster innovation, and ensure that scientific progress translates into real benefits for patients and society.
